Adenosine in myocardial perfusion imaging using positron emission tomography

Naresh C. Gupta, Dennis Esterbrooks, Syed Mohiuddin, Dan Hilleman, John Sunderland, Chyng Y. Shiue, Mathis P. Frick

Research output: Contribution to journalArticlepeer-review

19 Scopus citations


Because of its unique ability to demonstrate the metabolic consequences of myocardial ischemia, positron emission tomography (PET) is extremely valuable in assessing myocardial viability. PET imaging can identify the myocardial segments that are likely to improve after revascularization and may be more sensitive and specific for the detection of coronary artery disease compared with thallium perfusion imaging. Adenosine has several advantages over dipyridamole as a pharmacologic stress agent for use with PET. It produces maximal vasodilation in a significantly greater percentage of patients, is a more potent coronary vasodilator, and its very short half-life may be ideal for use with the very short half-life radioactive tracers used in PET. When combined with metabolic studies, adenosine may be useful for the assessment of patients who received thrombolytic therapy for an acute myocardial infarction.

Original languageEnglish (US)
Pages (from-to)293-301
Number of pages9
JournalAmerican Heart Journal
Issue number1 PART 1
StatePublished - Jul 1991

All Science Journal Classification (ASJC) codes

  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Adenosine in myocardial perfusion imaging using positron emission tomography'. Together they form a unique fingerprint.

Cite this